The store will not work correctly when cookies are disabled.
N-Phenyl-5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-amine
ID: ALA5078972
PubChem CID: 156770991
Max Phase: Preclinical
Molecular Formula: C15H10F3N3S
Molecular Weight: 321.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: FC(F)(F)c1ccc(-c2nnc(Nc3ccccc3)s2)cc1
Standard InChI: InChI=1S/C15H10F3N3S/c16-15(17,18)11-8-6-10(7-9-11)13-20-21-14(22-13)19-12-4-2-1-3-5-12/h1-9H,(H,19,21)
Standard InChI Key: VPXGRSFZEBMZJH-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
7.8005 -27.4254 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.2132 -28.1353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6216 -27.4229 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.0999 -29.3668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8072 -29.7753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5132 -29.3653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5112 -28.5472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7973 -28.1409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0942 -28.5533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9266 -28.5411 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.3913 -29.7814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6436 -29.4516 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.0989 -30.0608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5099 -30.7671 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3086 -30.5944 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2859 -29.9781 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9509 -29.2327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4297 -28.5737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0954 -27.8288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2815 -27.7456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8031 -28.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1401 -29.1556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
7 2 1 0
2 10 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 2 0
4 11 1 0
13 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 321.33 | Molecular Weight (Monoisotopic): 321.0548 | AlogP: 4.97 | #Rotatable Bonds: 3 |
Polar Surface Area: 37.81 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.74 | CX Basic pKa: 0.20 | CX LogP: 4.78 | CX LogD: 4.77 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.74 | Np Likeness Score: -2.00 |
References
1. Tantawy AH, El-Behairy MF, Abd-Allah WH, Jiang H, Wang MQ, Marzouk AA.. (2021) Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Fluorinated Candidates as PI3K Inhibitors: Targeting Fluorophilic Binding Sites., 64 (23.0): [PMID:34791873] [10.1021/acs.jmedchem.1c01674] |